Comparative clinical and economic analysis of using SYSADOA drugs containing chondroitin sulphate or influencing its biosynthesis in the treatment of patients with stage II knee osteoarthritis
Sarvilina, I. V., Galustyan, A. N., Hadzhidis, A. K., Sardaryan, I. S., Lavrov, N. V., Gromova, O. A., Prokofieva, Yu. S.
Published in Farmakoèkonomika (Moskva. Online) (18.02.2020)
Published in Farmakoèkonomika (Moskva. Online) (18.02.2020)
Get full text
Journal Article